Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.
Bermejo J, Yotti R, García-Orta R, Sánchez-Fernández PL, Castaño M, Segovia-Cubero J, Escribano-Subías P, San Román JA, Borrás X, Alonso-Gómez A, Botas J, Crespo-Leiro MG, Velasco S, Bayés-Genís A, López A, Muñoz-Aguilera R, de Teresa E, González-Juanatey JR, Evangelista A, Mombiela T, González-Mansilla A, Elízaga J, Martín-Moreiras J, González-Santos JM, Moreno-Escobar E, Fernández-Avilés F; Sildenafil for Improving Outcomes after VAlvular Correction (SIOVAC) investigators. Bermejo J, et al. Eur Heart J. 2018 Apr 14;39(15):1255-1264. doi: 10.1093/eurheartj/ehx700. Eur Heart J. 2018. PMID: 29281101 Free PMC article. Clinical Trial.
Long-Term Outcomes Among a Nationwide Cohort of Patients Using an Implantable Cardioverter-Defibrillator: UMBRELLA Study Final Results.
Briongos-Figuero S, García-Alberola A, Rubio J, Segura JM, Rodríguez A, Peinado R, Alzueta J, Martínez-Ferrer JB, Viñolas X, Fernández de la Concha J, Anguera I, Martín M, Cerdá L, Pérez L; UMBRELLA Investigators *. Briongos-Figuero S, et al. J Am Heart Assoc. 2021 Jan 5;10(1):e018108. doi: 10.1161/JAHA.120.018108. Epub 2020 Dec 25. J Am Heart Assoc. 2021. PMID: 33356406 Free PMC article.
Persistent Pulmonary Hypertension in Corrected Valvular Heart Disease: Hemodynamic Insights and Long-Term Survival.
Bermejo J, González-Mansilla A, Mombiela T, Fernández AI, Martínez-Legazpi P, Yotti R, García-Orta R, Sánchez-Fernández PL, Castaño M, Segovia-Cubero J, Escribano-Subias P, Alberto San Román J, Borrás X, Alonso-Gómez A, Botas J, Crespo-Leiro MG, Velasco S, Bayés-Genís A, López A, Muñoz-Aguilera R, Jiménez-Navarro M, González-Juanatey JR, Evangelista A, Elízaga J, Martín-Moreiras J, González-Santos JM, Moreno-Escobar E, Fernández-Avilés F; SIOVAC (“Sildenafil for Improving Outcomes after VAlvular Correction”) Investigators. Bermejo J, et al. J Am Heart Assoc. 2021 Jan 19;10(2):e019949. doi: 10.1161/JAHA.120.019949. Epub 2021 Jan 5. J Am Heart Assoc. 2021. PMID: 33399006 Free PMC article. Clinical Trial.
[The intracoronary infusion of superoxide dismutase during the initial liberation of oxygen free radicals induced by reperfusion. The effect on the infarct size after 60 minutes of coronary occlusion in the pig model].
Alonso Martín J, García-Dorado D, Soriano Triguero J, Botas Rodríguez J, Fernández Avilés F, Muñoz Aguilera R, Durán Hernández JM, Elízaga Corrales J, Esteban Paul E, Theroux P. Alonso Martín J, et al. Rev Esp Cardiol. 1991 Aug-Sep;44(7):462-72. Rev Esp Cardiol. 1991. PMID: 1661909 Spanish.
Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
Braunschweig F, Ford I, Conraads V, Cowie MR, Jondeau G, Kautzner J, Lunati M, Munoz Aguilera R, Man Yu C, Marijianowski M, Borggrefe M, van Veldhuisen DJ; DOT-HF steering committee and investigators. Braunschweig F, et al. Eur J Heart Fail. 2008 Sep;10(9):907-16. doi: 10.1016/j.ejheart.2008.06.016. Epub 2008 Aug 19. Eur J Heart Fail. 2008. PMID: 18715826 Free article. Clinical Trial.
Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
Briongos-Figuero S, Estévez A, Luisa Pérez M, Martínez-Ferrer JB, García E, Viñolas X, Arenal Á, Alzueta J, Basterra N, Rodríguez A, Lozano I, Muñoz-Aguilera R. Briongos-Figuero S, et al. Int J Cardiol. 2019 Jan 1;274:163-169. doi: 10.1016/j.ijcard.2018.09.003. Epub 2018 Sep 5. Int J Cardiol. 2019. PMID: 30206014
Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices.
Briongos-Figuero S, Sánchez A, Pérez ML, Martínez-Ferrer JB, García E, Viñolas X, Arenal Á, Alzueta J, Basterra N, Rodríguez A, Lozano I, Muñoz-Aguilera R. Briongos-Figuero S, et al. J Interv Card Electrophysiol. 2019 Apr;54(3):267-275. doi: 10.1007/s10840-018-0494-0. Epub 2018 Dec 6. J Interv Card Electrophysiol. 2019. PMID: 30523511
38 results